114 related articles for article (PubMed ID: 38159989)
41. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Lin H; Wang L; Zhong X; Zhang X; Shao L; Wu J
World J Surg Oncol; 2021 May; 19(1):141. PubMed ID: 33952287
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of a novel dNLR-PNI score in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Fan W; Liu Y; Zhang Y; Gao X; Shi F; Liu J; Sun L
Perfusion; 2023 Jul; 38(5):973-982. PubMed ID: 35608438
[TBL] [Abstract][Full Text] [Related]
43. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
[TBL] [Abstract][Full Text] [Related]
44. Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?
Menon A; Abraham AG; Mahfouz M; Thachuthara JJ; Usmani N; Warkentin H; Ghosh S; Nijjar T; Severin D; Tankel K; Paulson K; Mulder K; Roa W; Joseph K
Am J Clin Oncol; 2021 Sep; 44(9):487-494. PubMed ID: 34269694
[TBL] [Abstract][Full Text] [Related]
45. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancer.
Yamada Y; Sakamoto S; Rii J; Yamamoto S; Kamada S; Imamura Y; Nakamura K; Komiya A; Nakatsu H; Ichikawa T
Prostate; 2020 May; 80(7):559-569. PubMed ID: 32134137
[TBL] [Abstract][Full Text] [Related]
47. Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Mehraj A; Baba AA; Khan B; Khan MA; Wani RA; Parray FQ; Chowdri NA
J Cancer Res Ther; 2022 Dec; 18(Supplement):S391-S396. PubMed ID: 36510993
[TBL] [Abstract][Full Text] [Related]
48. A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy.
Li S; Wang Y; Cai H; Pan Z; Guan G
Int J Colorectal Dis; 2023 Jul; 38(1):184. PubMed ID: 37395868
[TBL] [Abstract][Full Text] [Related]
49. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy.
Jang JY; Oh D; Noh JM; Sun JM; Kim HK; Shim YM
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1167-1176. PubMed ID: 38613258
[TBL] [Abstract][Full Text] [Related]
50. Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study.
Huang X; Zheng Z; Zeng B; Xiao H; Zheng H; Lin Z; Song J; Li A; Chi P; Yang Y; Xu B; Zheng R
BMC Cancer; 2023 Mar; 23(1):238. PubMed ID: 36918865
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of carcinoembryonic antigen combined with carbohydrate antigen 19-9 following neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Zheng Z; Wang X; Lu X; Huang Y; Chi P
Colorectal Dis; 2021 Sep; 23(9):2320-2330. PubMed ID: 33900006
[TBL] [Abstract][Full Text] [Related]
53. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY
Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797
[TBL] [Abstract][Full Text] [Related]
54. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy.
Sun Y; Zhang Y; Huang Z; Lin H; Lu X; Huang Y; Chi P
World J Surg; 2020 Jun; 44(6):1975-1984. PubMed ID: 32020327
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Baek JH; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
In Vivo; 2020; 34(4):1993-1999. PubMed ID: 32606172
[TBL] [Abstract][Full Text] [Related]
56. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
[TBL] [Abstract][Full Text] [Related]
57. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
58. The prognostic value of preoperative derived neutrophil-to-lymphocyte ratio in patients undergoing total laryngectomy with laryngeal carcinoma.
Song S; Chen H; Dong W; Zhou H
Acta Otolaryngol; 2019 Mar; 139(3):294-298. PubMed ID: 30882257
[TBL] [Abstract][Full Text] [Related]
59. The Prognostic Value of a Derived Neutrophil-Lymphocyte Ratio in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Fan W; Zhang Y; Gao X; Liu Y; Shi F; Liu J; Sun L
Clin Appl Thromb Hemost; 2021; 27():10760296211034579. PubMed ID: 34286626
[TBL] [Abstract][Full Text] [Related]
60. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
